MTFR2 regulated the proliferation, apoptosis, migration, and invasion of endometrial cancer cells through the Drp1/MFN1 signaling pathway mediated mitochondrial fission
Authors:
- Xuefei BaiXBXuefei Bai
- Min WeiMWMin Wei
- Qi WangQWQi Wang
- Yongxiu YangYYYongxiu Yang
Open Access
- 1 April 2026
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 15 (4) , 318
Abstract
Background: Mitochondrial dynamics play a critical role in tumor progression, yet the contribution of mitochondrial fission regulator 2 (MTFR2) to endometrial cancer (EC) remains poorly defined. This study investigated the clinical relevance and functional role of MTFR2 in EC and explored its involvement in mitochondrial dynamics mediated by the dynamin-related protein 1 (Drp1)/mitochondrial fusion protein mitofusin 1 (MFN1) signaling axis. Methods: The expression levels of MTFR2 in EC tissues and normal endometrial tissues were analyzed using quantitative real-time polymerase chain reaction (qRT-PCR), Western blot, and immunohistochemistry (IHC). The effects of MTFR2 on the proliferation, apoptosis, migration, and invasion abilities of EC cells were evaluated using Cell Counting Kit-8 (CCK-8), colony formation, 5-ethynyl-2'-deoxyuridine (EdU), scratch wound healing, and Transwell assays. A nude mouse subcutaneous xenograft tumor model was constructed to verify the role of MTFR2 in vivo, and changes in the activity of the Drp1/MFN1 signaling pathway were detected. Results: MTFR2 was significantly upregulated in EC tissues associated with patient age, clinical stage, pathological type, histological grade, depth of tumor invasion, and treatment response. Overexpression of MTFR2 promoted the proliferation, clonogenicity, DNA synthesis, migration, and invasion of EC cells; in contrast, knockdown of MTFR2 inhibited these malignant phenotypes. Additionally, MTFR2 regulated the activity of the Drp1/MFN1 signaling pathway: its overexpression increased Drp1 phosphorylation and decreased MFN1 expression, whereas MTFR2 knockdown reduced Drp1 phosphorylation and increased MFN1 levels. In vivo experiments demonstrated that silencing MTFR2 significantly suppressed subcutaneous tumor growth in nude mice and reduced the expression of Ki-67 and proliferating cell nuclear antigen (PCNA) in tumor tissues. Conclusions: MTFR2 is highly expressed in EC and is correlated with a poor prognosis and aggressive tumor behavior. It promotes proliferation, apoptosis, migration, and invasion of EC cells by regulating the Drp1/MFN1 signaling pathway. This suggests that MTFR2 could potentially be a molecular target for the diagnosis and treatment of EC.Keywords
This publication has 28 references indexed in Scilit:
- Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastasesNature Cancer, 2023
- The Complex Roles of DNA Repair Pathways, Inhibitors, Hyperthermia, and Contact Inhibition in Cell Cycle HaltsMini-Reviews in Medicinal Chemistry, 2023
- Role of Genomic and Molecular Biology in the Modulation of the Treatment of Endometrial Cancer: Narrative Review and PerspectivesHealthcare, 2023
- Association of mitochondrial homeostasis and dynamic balance with malignant biological behaviors of gastrointestinal cancerJournal of Translational Medicine, 2023
- MTFR2 shapes a barrier of immune microenvironment in hepatocellular carcinomaiScience, 2022
- Aerobic exercise suppresses hepatocellular carcinoma by downregulating dynamin-related protein 1 through PI3K/AKT pathwayJournal of Integrative Medicine, 2021
- Suppressing Cdk5 Activity by Luteolin Inhibits MPP+-Induced Apoptotic of Neuroblastoma through Erk/Drp1 and Fak/Akt/GSK3β PathwaysMolecules, 2021
- MTFR2, A Potential Biomarker for Prognosis and Immune Infiltrates, Promotes Progression of Gastric Cancer Based on Bioinformatics Analysis and ExperimentsJournal of Cancer, 2021
- Polyphyllin VII induces mitochondrial apoptosis by regulating the PP2A/AKT/DRP1 signaling axis in human ovarian cancerOncology Reports, 2020
- Correction for: Mitochondrial fission regulator 2 (MTFR2) promotes growth, migration, invasion and tumour progression in breast cancer cellsAging, 2020